Philadelphia VA Medical Center; Perelman School of Medicine, University of Pennsylvania; and Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Global Health, Boston University School of Public Health, Boston, MA, USA.
Clin Exp Rheumatol. 2019 Sep-Oct;37(5):768-773. Epub 2019 Jan 18.
Obesity is paradoxically associated with a lower risk of mortality in chronic illnesses including rheumatoid arthritis (RA). Weight loss in patients with poor health, however, may in part explain this observation. This study evaluated the impact of weight early in life and weight loss on mortality in patients with RA.
Patients with RA (age >40 years) were active participants in a prospective clinical registry with up to 17 years of follow-up. Current and age-30 body mass index (BMI) were determined from self-report of height and weight from semi-annual questionnaires. Mortality was assessed from National Death Index. Risks of obesity reported from both early in life and at enrolment in the registry were evaluated using Cox proportional hazards models.
Among 12,679 participants (80% female), there were 1,520 deaths in 80,502 person-years. Obesity at enrolment (BMI >30 kg/m2) was modestly associated with greater mortality [HR: 1.34 (1.18,1.53) p=0.001]. Adjusting for disability and comorbidities hypothesised to be mediators in the causal pathway between obesity and mortality further attenuated this association [HR: 0.92 (0.80,1.06) p=0.24]. In contrast, obesity at age 30 was strongly associated with mortality [HR: 2.00 (1.65,2.42) p<0.001]. Additionally, weight loss since age-30 was a strong, dose-dependent predictor of mortality independent of enrolment BMI.
The risk of obesity is substantially underestimated when epidemiologic methods do not account for long-term weight changes. Both obesity and weight loss are strongly associated with mortality risk in patients with RA.
肥胖与包括类风湿关节炎(RA)在内的慢性疾病的死亡率降低呈悖论关系。然而,身体状况较差的患者体重减轻可能在一定程度上解释了这一观察结果。本研究评估了生命早期和体重减轻对 RA 患者死亡率的影响。
年龄>40 岁的 RA 患者是前瞻性临床登记处的积极参与者,随访时间长达 17 年。通过半年度问卷中自我报告的身高和体重确定当前和 30 岁时的体重指数(BMI)。通过国家死亡指数评估死亡率。使用 Cox 比例风险模型评估早期和登记时肥胖报告的风险。
在 12679 名参与者(80%为女性)中,有 1520 人在 80502 人年中死亡。登记时肥胖(BMI>30kg/m2)与死亡率增加适度相关[风险比(HR):1.34(1.18,1.53)p=0.001]。调整残疾和共病,假设它们是肥胖与死亡率之间因果关系的中介因素,进一步减弱了这种关联[HR:0.92(0.80,1.06)p=0.24]。相比之下,30 岁时肥胖与死亡率密切相关[HR:2.00(1.65,2.42)p<0.001]。此外,体重减轻自 30 岁以来是独立于登记 BMI 的死亡率的强烈、剂量依赖性预测因素。
如果流行病学方法不考虑长期体重变化,肥胖的风险就会被大大低估。肥胖和体重减轻都与 RA 患者的死亡率密切相关。